Here's the live share price of Bal Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Bal Pharma has gained 13.29% CAGR. Over the past year, the corresponding return has been -32.61%.
Bal Pharma’s current P/E of 18.79x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Bal Pharma | -6.20 | -7.44 | -14.18 | 0.88 | -32.61 | -4.02 | 13.29 |
Sun Pharmaceutical Industries | 2.46 | 1.83 | 0.53 | -4.47 | -10.31 | 23.72 | 26.88 |
Divi's Laboratories | 2.72 | 1.77 | -4.66 | 6.42 | 13.89 | 19.59 | 14.40 |
Cipla | 0.10 | 1.71 | 6.22 | 5.14 | -3.85 | 15.04 | 15.46 |
Torrent Pharmaceuticals | 2.14 | -0.21 | 14.98 | 14.09 | 8.71 | 35.04 | 21.92 |
Dr. Reddy's Laboratories | 0.55 | 6.29 | -0.21 | 12.94 | 1.71 | 17.31 | 5.19 |
Mankind Pharma | 3.11 | 6.77 | 14.52 | 23.06 | 9.42 | 23.16 | 13.31 |
Zydus Lifesciences | -0.75 | 4.85 | 9.18 | 14.01 | -1.65 | 42.32 | 21.23 |
Lupin | 0.75 | 4.56 | 6.49 | -0.13 | -5.17 | 47.48 | 14.61 |
Alkem Laboratories | 2.04 | 3.13 | 16.34 | 14.54 | -9.45 | 19.64 | 14.17 |
Aurobindo Pharma | 2.17 | 2.57 | 3.24 | -3.89 | -26.78 | 29.10 | 7.17 |
Abbott India | -1.82 | -8.05 | -1.97 | 0.22 | 8.72 | 20.47 | 13.85 |
Glenmark Pharmaceuticals | -2.16 | 7.13 | 27.12 | 40.23 | 26.25 | 77.84 | 34.53 |
Laurus Labs | 4.19 | 5.51 | 44.52 | 54.04 | 98.51 | 22.52 | 26.75 |
Biocon | 1.26 | 1.57 | 6.05 | 8.19 | 2.48 | 8.42 | -2.92 |
Anthem Biosciences | 1.98 | 3.87 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
GlaxoSmithKline Pharmaceuticals | -1.38 | -2.86 | -14.32 | -3.47 | 1.40 | 24.71 | 10.06 |
Ipca Laboratories | 6.86 | 1.39 | 3.24 | 3.63 | -3.35 | 17.89 | 6.17 |
Cohance Lifesciences | -7.40 | -1.19 | -8.09 | -21.72 | -22.85 | 25.51 | 19.13 |
Gland Pharma | 0.04 | 3.93 | 18.34 | 27.73 | 11.67 | -3.43 | 2.12 |
Over the last one year, Bal Pharma has declined 32.61% compared to peers like Sun Pharmaceutical Industries (-10.31%), Divi's Laboratories (13.89%), Cipla (-3.85%). From a 5 year perspective, Bal Pharma has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Day | SMA | EMA |
---|---|---|
5 | 89.3 | 87.53 |
10 | 88.8 | 88.16 |
20 | 88.57 | 89.05 |
50 | 93.62 | 92.17 |
100 | 96.94 | 95.72 |
200 | 102.22 | 100.74 |
In the latest quarter, Bal Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 0.15%, and public shareholding moved down to 48.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 02, 2025, 8:57 PM IST | Bal Pharma Ltd - Reg. 34 (1) Annual Report. |
Aug 12, 2025, 11:08 PM IST | Bal Pharma Ltd - Corporate Action-Fixes Record Date For Dividend. |
Aug 11, 2025, 11:40 PM IST | Bal Pharma Ltd - Unaudited Financial For The Quarter Ended 30.06.2025. |
Aug 11, 2025, 11:34 PM IST | Bal Pharma Ltd - Board Meeting Outcome for Outcome Of The Board Meeting |
Jul 29, 2025, 10:18 PM IST | Bal Pharma Ltd - Board Meeting Intimation for Inter Alia Take On Record And Approve The Unaudited Financial Results For The Q |
Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 302.50 Cr. and Equity Capital is Rs. 15.92 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bal Pharma is ₹84.44 as on Sep 19, 2025.
The Bal Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Bal Pharma is ₹134.44 Cr as on Sep 19, 2025.
Today’s highest and lowest price of Bal Pharma are ₹87.99 and ₹82.00.
The 52-week high/low is the highest and lowest price at which Bal Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bal Pharma is ₹141.15 and 52-week low of Bal Pharma is ₹76.30 as on Sep 19, 2025.
The Bal Pharma has shown returns of -0.05% over the past day, -7.44% for the past month, -14.18% over 3 months, -32.61% over 1 year, -4.02% across 3 years, and 13.29% over 5 years.
P/E ratio of and PB ratio of Bal Pharma are 18.79 and 1.95 on Sep 19, 2025. While the company gives a dividend yield of 1.42 per annum.